check_circleStudy Completed

Magnetic Resonance Imaging

Bayer Identifier:
Trial_A23CQB
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Gd-DTPA in body trunk and extremities

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

15 - 70 Years
  • -

  • -

Trial summary

Enrollment Goal
455
Trial Dates
January 1987 - January 1988
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Phase II study with Gd-DTPA in body trunk and extremities
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.